Karuna Pharmaceuticals' Grant

Karuna Pharmaceuticals raised a round of funding on February 14, 2009. Investors include Qualifying Therapeutic Discovery Project.

Karuna is a clinical-stage drug development company targeting muscarinic receptors for the treatment of psychosis and cognition across central nervous system (CNS) disorders, including schizophrenia a…

Articles about Karuna Pharmaceuticals' Grant: